About: New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 September 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articol științific (ro) articolo scientifico (it) artigo científico (gl) artigo científico (pt) artigo científico (pt-br) artikull shkencor (sq) artículo científico (es) artículu científicu (ast) bilimsel makale (tr) scienca artikolo (eo) vedecký článok (sk) vetenskaplig artikel (sv) vitenskapelig artikkel (nb) vitskapeleg artikkel (nn) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научная статья (ru) научни чланак (sr) מאמר מדעי (he) artikel ilmiah (id) article scientifique (fr) বৈজ্ঞানিক নিবন্ধ (bn) наукова стаття, опублікована у вересні 2011 (uk) scientific article published on 22 September 2011 (en) scientific article published on 22 September 2011 (en-ca) scientific article published on 22 September 2011 (en-gb) مقالة علمية نشرت في 22 سبتمبر 2011 (ar)
publication date	wds:Q37937083-74EE0CD0-1F78-4D11-BA5A-02BD1EB2846A
publication date	2011-09-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37937083-7F5CCBE3-714D-4842-B635-8A623B45E92D
language of work or name	English
exact match	wds:Q37937083-71846EAD-D0EB-4D9E-8B56-AFB0631688D3
exact match	https://scigraph.springernature.com/pub.10.1186/1824-7288-37-46
cites work	wds:Q37937083-04D2D6B7-2174-4062-9971-B2966EBA032E wds:Q37937083-0FFB96F2-F1C2-49F5-AD0F-84AB45D0C8E2 wds:Q37937083-1C90E52A-A38A-419F-8E36-08C0056C6C61 wds:Q37937083-2F816B65-4194-4D28-BB9A-A243CC7B8CE4 wds:Q37937083-3AB7B366-8183-4B2D-A7EE-A1F62B2241FB wds:Q37937083-3DAF9C9C-DD76-4993-A8C7-F4E4DDAEE996 wds:Q37937083-43823E0D-8865-424A-ACFC-622D1E51A3D5 wds:Q37937083-497E6B5D-88DD-43E0-ACD5-550B25CF5DF3 wds:Q37937083-4D71B1FF-1147-4192-88B3-304423598C02 wds:Q37937083-4DBF405E-6A88-451D-9326-F04746634904 wds:Q37937083-51CB673F-7321-499B-A94A-A74EFE61736D wds:Q37937083-5872C7B9-AD0F-4043-8F38-A409BE559C48 wds:Q37937083-5F73FD4F-3096-4648-BF92-0DAC71ED5625 wds:Q37937083-6470C3C4-2AA2-491D-ACAF-D780349BE68B wds:Q37937083-64B8DFA2-ECE6-4F2B-A211-CEA91AA50181 wds:Q37937083-7B08F997-E812-4421-B31F-D8D127B2D841 wds:Q37937083-7F878F73-6387-4BCE-B2F9-F32EDA9E61C5 wds:Q37937083-84908064-0B4F-4D07-8FB6-B37DD54B5FE7 wds:Q37937083-84BAD9CB-7CAA-40D6-8137-7750EAEF9E22 wds:Q37937083-8D2D4E0D-A587-4F57-B18D-B0D46A00E911 wds:Q37937083-8FC149F1-B82A-465D-BDA1-B9268681FD9C wds:Q37937083-91B8BF10-ACF2-4115-96F6-A918C06CFA8B wds:Q37937083-953E1C0A-63D5-4A01-AE3A-92020DC1E408 wds:Q37937083-964735C1-27B7-40F7-BE4F-7DE2EE504DE1 wds:Q37937083-96CCDF78-5AE7-46D6-A321-2AD9F0FAAA01 wds:Q37937083-9B43BE77-3ED5-4DF1-876C-6EC0D6EC9168 wds:Q37937083-AE59FC2E-B44C-4013-BFED-C8D820618F52 wds:Q37937083-B07418E1-C461-4FE4-9D0A-687EC8EFF512 wds:Q37937083-B210D096-4814-4D53-84C6-FB214CCF463E wds:Q37937083-B690323F-796C-4A80-A0E0-723FB3C3592B wds:Q37937083-BF675ED8-8B0F-4B44-9832-970D3096D57F wds:Q37937083-C500C635-0277-4B03-85FB-F5BCFBC3D1AB wds:Q37937083-C99B9C81-22B9-455E-9D55-051C89216980 wds:Q37937083-CEB5469D-943D-4FFE-8583-BD98A7C662B3 wds:Q37937083-D82403C6-7DB2-4C59-8EE1-F65D644E4A9F wds:Q37937083-DAD060BD-AA46-4668-BF15-8830B0815684 wds:Q37937083-E198BFEA-040A-43DF-B514-477D31CFE519 wds:Q37937083-EE1A510D-4013-45F8-8B50-8E27C4812CD9 wds:Q37937083-F0C8587B-3121-4D6B-B9E9-CFCD4CD8EBAF wds:Q37937083-F903DC0F-DAF8-496D-AFBC-A1586213A272
cites work	Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes PD-1 and PD-1 ligands: from discovery to clinical application Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy Supernatural T cells: genetic modification of T cells for cancer therapy Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells Genetic modification of T lymphocytes for adoptive immunotherapy Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy Safer CARS. Assembly PCR oligo maker: a tool for designing oligodeoxynucleotides for constructing long DNA molecules for RNA production. Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010 The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software